MedPath

Preemptive Analgesia With Morphine Sulphate in Major Urological Surgery

Conditions
Pain
Registration Number
NCT02041988
Lead Sponsor
University of Roma La Sapienza
Brief Summary

In this study safety and efficacy of oral morphine sulphate is evaluated in order to reduce opioids administration during major urological surgery

Detailed Description

The administration of oral morphine sulfate could be useful to reduce the use of opioids in major urological surgery. This study aims to assess the safety and efficacy of two different oral morphine sulphate doses 0,2 mg/kg vs 0,4mg/kg in major urological surgery.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria

American Society of Anaesthesiologists physical status classification I/ II, age between 18 - 75, BMI 18 -30

Exclusion Criteria

American Society of Anaesthesiologists physical status classification III/ IV, renal and hepatic insufficiency, postoperative nausea and vomiting after oral opioids administrations, neurological and psychiatric disorders.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
morphine sulphate consumptionsix months
Secondary Outcome Measures
NameTimeMethod
vital signssix months

Trial Locations

Locations (2)

Policlinico Umberto I

🇮🇹

Rome, Italy

Francesco Cannata

🇮🇹

Rome, Italy

© Copyright 2025. All Rights Reserved by MedPath